BACKGROUND With the increase in molecular genetic understanding of disease, diagnostic test development and availability are growing rapidly. This study investigated oncologists' decision making on using pharmacogenomic tests for cancer treatment and examined cross-cultural differences between the USA and Germany. METHODS Pilot studies revealed that the following cues play a role in decisions...


 Pharmacogenomic testing is a precision medicine technology that examines genetic variation in medication metabolism. Selected for inclusion CADTH’s 2023 Watch List, pharmacogenomic has the potential to significantly influence landscape of health care Canada over next 5 years. By analyzing an individual’s unique profile, this aims guide personalized treatment strategies improve therapeuti...